Switch of glycolysis to gluconeogenesis by dexamethasone for treatment of hepatocarcinoma.
about
Integrative quantitative proteomics unveils proteostasis imbalance in human hepatocellular carcinoma developed on nonfibrotic livers.Control of hepatic gluconeogenesis by the promyelocytic leukemia zinc finger protein.A novel 11β-hydroxysteroid dehydrogenase type1 inhibitor CNX-010-49 improves hyperglycemia, lipid profile and reduces body weight in diet induced obese C57B6/J mice with a potential to provide cardio protective benefits.Upregulation of cytosolic phosphoenolpyruvate carboxykinase is a critical metabolic event in melanoma cells that repopulate tumors.Loss of 11βHSD1 enhances glycolysis, facilitates intrahepatic metastasis, and indicates poor prognosis in hepatocellular carcinomaNovel small molecule 11β-HSD1 inhibitor from the endophytic fungus Penicillium commune.PARP14 promotes the Warburg effect in hepatocellular carcinoma by inhibiting JNK1-dependent PKM2 phosphorylation and activation.Glucocorticoid Receptor-Targeted Liposomal Codelivery of Lipophilic Drug and Anti-Hsp90 Gene: Strategy to Induce Drug-Sensitivity, EMT-Reversal, and Reduced Malignancy in Aggressive Tumors.Nur77 suppresses hepatocellular carcinoma via switching glucose metabolism toward gluconeogenesis through attenuating phosphoenolpyruvate carboxykinase sumoylation.Inhibiting histone deacetylases suppresses glucose metabolism and hepatocellular carcinoma growth by restoring FBP1 expression.SIR-2.1 integrates metabolic homeostasis with the reproductive neuromuscular excitability in early aging male Caenorhabditis elegans.mTORC2 controls cancer cell survival by modulating gluconeogenesis.Metabolomics Analysis of the Osteogenic Differentiation of Umbilical Cord Blood Mesenchymal Stem Cells Reveals Differential Sensitivity to Osteogenic Agents.Gluconeogenesis combats cancer: opening new doors in cancer biology.Identification of glycerol-3-phosphate dehydrogenase 1 as a tumour suppressor in human breast cancer.YAP suppresses gluconeogenic gene expression through PGC1α.Oxidative phosphorylation activation is an important characteristic of DOX resistance in hepatocellular carcinoma cells.Targeting FBPase is an emerging novel approach for cancer therapy.Metabolic reprogramming enables hepatocarcinoma cells to efficiently adapt and survive to a nutrient-restricted microenvironment.Function of mitochondrial pyruvate carriers in hepatocellular carcinoma patients.A precision therapeutic strategy for hexokinase 1-null, hexokinase 2-positive cancers.Comprehensive analysis of multi Ewing sarcoma microarray datasets identifies several prognosis biomarkersNovel sericin-based hepatocyte serum-free medium and sericin's effect on hepatocyte transcriptomeAnalysis of differentially expressed genes among human hair follicle-derived iPSCs, induced hepatocyte-like cells, and primary hepatocytesRestoration of FBP1 suppressed Snail-induced epithelial to mesenchymal transition in hepatocellular carcinoma
P2860
Q30397531-10156F18-49BE-48E8-8E75-7D6CEDAE20ECQ33631885-02091E7A-29E4-4713-81DE-CB466576ED40Q34023395-5CCE5A5A-8A00-4821-95C8-47496513895CQ36239593-DE8B8587-7210-4549-8DE0-F6D174C9B15EQ36739034-9AD3B347-ED6D-4B8F-8597-45DA27A1B787Q36914904-8225D2BB-E1B3-4666-935C-415941D8FB0FQ37031827-567270EA-8198-4EA8-A172-2B56F0442014Q37644744-0F9E53E1-48EE-4601-BE40-66DC3F2D85EAQ37676708-CDDD751D-403F-43F6-B19F-C42316A22C2AQ37682212-977A8EA2-2BBD-45AE-94D4-887A3A9C917EQ38797285-B4296EB3-E547-4673-A25D-74CEAC2BF61FQ39463791-D4D31604-9E33-410F-8AED-A210C99C6A13Q42111360-38EE4B1C-73DB-4D15-807C-6A26ED9712ADQ43167145-3B814E8E-4E56-411F-8D8D-36A60A04CEE6Q47127880-33CE22CB-CE6A-4B4C-9247-E8ADE7984B47Q47917310-AD2133B6-1355-470D-948D-593CCF873558Q48041763-94B951B3-1FE4-4078-85B2-10C442C0089AQ52647812-19F8607E-94E2-4A67-ADA5-CA3B0C20C4F4Q52720378-6294D941-C472-438E-A1FE-1F27C62F5607Q55040240-E7E8DCC1-2D62-45C2-A022-5A78131EB617Q55471490-AF5EAA3D-1897-4A5E-8345-786CEB5D3ADFQ58766236-B37B1009-4388-4C8E-B8D5-C952049A5CC1Q58782767-90A66416-3E24-47DC-B258-91EDC349008EQ58793555-8A8A67EF-DE6A-4429-8C13-3DBA55DE7065Q59137601-9B7869FD-9205-422B-A78E-FEC72E93AF07
P2860
Switch of glycolysis to gluconeogenesis by dexamethasone for treatment of hepatocarcinoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Switch of glycolysis to glucon ...... treatment of hepatocarcinoma.
@en
Switch of glycolysis to glucon ...... treatment of hepatocarcinoma.
@nl
type
label
Switch of glycolysis to glucon ...... treatment of hepatocarcinoma.
@en
Switch of glycolysis to glucon ...... treatment of hepatocarcinoma.
@nl
prefLabel
Switch of glycolysis to glucon ...... treatment of hepatocarcinoma.
@en
Switch of glycolysis to glucon ...... treatment of hepatocarcinoma.
@nl
P2093
P2860
P356
P1476
Switch of glycolysis to glucon ...... treatment of hepatocarcinoma.
@en
P2093
Foad Katirai
Huafeng Zhang
Pingwei Xu
Shunqun Luo
Tiantian Ji
P2860
P2888
P356
10.1038/NCOMMS3508
P407
P577
2013-01-01T00:00:00Z